成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghai Yifei Biotechnology Co. , Ltd.??? ?? ??? ?????.

?? ?:Shanghai Yifei Biotechnology Co. , Ltd.
??:021-65675885
???:customer_service@efebio.com
??:China
URL: http://www.efebio.com
? ?? ?:11974

?? ????

IL-17A antagonist 12205034-18-8C33H41FN6O4
TLR7/8-IN-12205095-75-4C29H40N8O2
Simazine-d5220621-41-0C7H12ClN5
Ruplizumab?????220651-94-5
Sasanlimab2206792-50-7
Ragifilimab2207590-51-8
RO0270608220846-33-3C24H19Cl3N2O4
MMV6888452208962-35-8C24H25N3O3S
4,4-Diphenylbutylamine hydrochloride22101-90-2C16H20ClN
Crobenetine221019-25-6C25H33NO2
Mal-amide-PEG8-Val-Ala-PAB-PNP2210247-59-7C48H68N6O19
(S)-Desmethyl-NNC112(S)-????-NNC112221132-62-3C18H16ClNO2
Nec-34i2212541-00-7C21H19N3O2S
Petosemtamab2213450-26-9
AZD81542215022-45-8C27H29N5O4S2
K-111221564-97-2C18H25Cl3O2
SCH 57790221660-80-6C25H31N3O2S
Cosibelimab2216751-26-5
Benzyl-PEG12-alcohol2218463-17-1C31H56O13
TZ3O2218754-19-7C18H13NO4S
Tuberculosis inhibitor 32219325-28-5C21H22F6N4O3S
SARS-CoV-2-IN-145-???-N-(3-?????)-2-?????-?????22203-98-1C13H9Cl2NO2
MI-3892222635-92-7C35H35FN6O6
Tafolecimab2225109-03-3
Gemnelatinib2225123-30-6C30H29FN6O2
PARP10-IN-32225800-19-9C14H12N2O3
Zelminemab2225850-33-7
RO71858762226038-71-5C25H28F3N7
Talquetamab2226212-40-2
Tinurilimab2226224-30-0
Bamocaftor2204245-48-5C28H32F3N5O4S
MY102204270-73-3C15H10F6OS2
MY33-32204280-41-9C16H13F6NS2
MY33-3 hydrochloride2204280-42-0C16H14ClF6NS2
Pexelizumab219685-93-5
Felzartamab2197112-39-1
Visilizumab?????219716-33-3
Pramiconazole??????219923-85-0C35H39F2N7O4
Zagociguat2201048-82-8C16H10F4N6
(S)-HH28532202678-05-3C31H36F3N7O3
(R)-HH28532202678-06-4C31H36F3N7O3
ALDH1A2-IN-12204229-64-9C21H26N4O4S
ATG7-IN-22226227-75-2C11H16N6O7S
Avdoralimab2226393-85-5
2'-O-(2-Azidoethyl)adenosine2226475-42-7C12H16N8O4
NV-54402226614-88-4C31 H36 N6 O3 S
AVG-2332151937-80-1C26H22ClN5O3
Propionanilide, 3'-hydroxy-N-(3-???????)??????21556-86-5C9H11NO2
Axatilimab2155851-88-8
Benproperine2156-27-6C21H27NO
Befovacimab2156634-62-5
CCCI-01215778-97-5C11H9N3O4
(R)-GSK-36850322170140-50-6C22H24N6OS
IRAK4-IN-212170694-04-7C28H28FN7O2
IRAK4-IN-222170694-05-8C28H28FN7O2
Bedinvetmab2171034-69-6
Relfovetmab2171034-70-9
Dovanvetmab2171034-71-0
Nidanilimab2171061-85-9
AKOS0376522562171065-77-1C24H26ClFN4O4S2
Arg-Gly-Asp-Cys TFA2171504-22-4C17H28F3N7O9S
Indole-C2-amide-C2-NH2215789-29-0C13H17N3O
Chst15-IN-12158198-77-5C17H11BrCl2N2O3
Navocaftor2159103-66-7C15H11F3N4O5S
Semorinemab2159141-27-0
Elsibucol????216167-95-2C35H54O4S2
Garadacimab2162134-62-3
Sonlicromanol hydrochloride2162149-24-6C19H29ClN2O3
DBCO-PEG3-NHS ester2163772-16-3C32H35N3O9
Mitumomab216503-58-1
Glucocorticoid receptor agonist-12166375-82-0C35H39NO6
Sibrotuzumab216669-97-5
Nurulimab2168561-20-2
Manelimab2168561-26-8
L 756423216863-66-0C39H48N4O5
SHP2-IN-6 hydrochloride2169223-49-6C22H27ClF2N6O2S
Magrolimab2169232-81-7
Thalidomide-O-C6-COOH2169266-69-5C20H22N2O7
KDM2A/7A-IN-12169272-46-0C33H38N4O
Atinvicitinib2169273-59-8C16H17FN6O3
SOCE inhibitor 12169316-15-6C25H22F3N5O4
Zanidatamab2169946-15-8
Amivantamab2171511-58-1
(S,R,S)-AHPC-CO-C9-acid2172819-78-0C33H48N4O6S
Astegolimab2173054-79-8
Encelimab2173096-82-5
INCB-0009282173389-57-4C30H38N4O3
Cytembena21739-91-3C11H9BrO4.Na
L-796,778217480-25-6C29H40N6O7
Monuron-d6217488-65-8C9H11ClN2O
Tau-aggregation and neuroinflammation-IN-12175953-98-5C25H20N2O7
TLR7 agonist 12178156-33-5C21H25N5O
Lenalidomide-PEG1-azide2185795-67-7C17H18N6O5
Disitamab2185868-98-6
Lacutamab2187368-16-5
Batoclimab2187430-05-1
LTβR-IN-12189366-77-4C18H16N4O2
PSMA I&T2192281-54-0C63H92IN11O23
Metronidazole-hydroxy-d22196180-19-3C6H9N3O4
Labetuzumab219649-07-7
Copyright 2019 ? ChemicalBook. All rights reserved